Related Experiment Videos
Borderline tuberculoid Hansen's disease in AIDS
D R Goodless1, A L Viciana, R J Pardo
1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33101.
Journal of the American Academy of Dermatology
|May 1, 1994
Summary
Human immunodeficiency virus (HIV) infection does not significantly alter the immune response to Mycobacterium leprae (Hansen's disease) in patients with AIDS. The skin lesions showed typical characteristics, indicating the immune system still fights leprosy effectively.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- Investigating the impact of Human Immunodeficiency Virus (HIV) infection on the immune response to Mycobacterium leprae (Hansen's disease).
- Examining a patient with Acquired Immunodeficiency Syndrome (AIDS) and borderline tuberculoid Hansen's disease.
Observation:
- Immunohistochemical analysis of skin lesions was performed.
- Peripheral blood flow cytometric analysis was conducted.
- Laboratory features associated with immunosuppression were evaluated.
Findings:
- The in situ immunologic response to Mycobacterium leprae was minimally affected by HIV infection and immunosuppression.
- Skin lesions exhibited characteristics typical of borderline tuberculoid Hansen's disease.
- Despite laboratory evidence of immunosuppression in AIDS, the immune response to M. leprae remained largely unchanged.
Implications:
- HIV infection does not substantially impair the host's immune response to Mycobacterium leprae.
- This suggests that Hansen's disease management in HIV-positive individuals may follow standard protocols.
- Further research into immune reconstitution and leprosy in co-infected patients is warranted.